Medtronic (MDT) Cash & Equivalents Growth (3y) (2016 - 2026)

Medtronic (MDT) Cash & Equivalents Growth (3y) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -9.44%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 19.87%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -36.69%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 36.60%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 40.99%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 34.11%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 21.52%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -0.70%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 28.25%
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn 8.71%

Historic Data

Download Data
DateValue
Jan 23, 2026 -36.69%
Oct 24, 2025 -35.73%
Jul 25, 2025 -15.90%
Apr 25, 2025 -15.79%
Jan 24, 2025 -29.10%
Oct 25, 2024 -21.67%
Jul 26, 2024 -24.15%
Apr 26, 2024 -29.04%
Jan 26, 2024 -31.62%
Oct 27, 2023 -41.11%
Jul 28, 2023 -40.94%
Apr 28, 2023 -28.03%
Jan 27, 2023 6.82%
Oct 28, 2022 6.81%
Jul 29, 2022 -25.04%
Apr 29, 2022 -5.44%
Jan 28, 2022 -2.06%
Oct 29, 2021 -9.49%
Jul 30, 2021 -11.81%
Apr 30, 2021 -0.70%